Adding interferon-α to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumours

被引：6

作者：

Pape, UF ^{[1
]}

Wiedenmann, B ^{[1
]}

机构：

[1] Charite, Dept Internal Med, Ctr Endocrinol & Metab, Div Hepatol & Gastroenterol & Interdisciplinary, Berlin, Germany

来源：

关键词：

D O I：

10.1016/j.ctrv.2003.07.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：565 / 569

页数：5